Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant change » significant changes (Expand Search), significant challenge (Expand Search), significant challenges (Expand Search)
change decrease » change increases (Expand Search), change degree (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant change » significant changes (Expand Search), significant challenge (Expand Search), significant challenges (Expand Search)
change decrease » change increases (Expand Search), change degree (Expand Search)
-
2001
Effects of <i>B</i>. <i>erecta</i> on walking by footprint test of PD model rats.
Published 2024Subjects: -
2002
-
2003
-
2004
Effects of <i>B</i>.<i>erecta</i> on PD model rats of Depressive-like symptom.
Published 2024Subjects: -
2005
Effects of <i>B</i>. <i>erecta</i> on PD model rats of social interaction test.
Published 2024Subjects: -
2006
-
2007
-
2008
Effects of <i>B</i>. <i>erecta</i> on motor symptom of PD model rats (Rotarod test).
Published 2024Subjects: -
2009
Clinical and epidemiological characteristics.
Published 2025“…Elderly individuals (aged ≥ 60 years) had smaller reductions in BMI and fat mass than non-elderly individuals (aged < 60 years) but still presented significant improvements. Conclusion: This study suggests the viability of treating severe obesity by hospitalization with low-calorie diets and immersive lifestyle changes. …”
-
2010
S1 Data -
Published 2025“…Elderly individuals (aged ≥ 60 years) had smaller reductions in BMI and fat mass than non-elderly individuals (aged < 60 years) but still presented significant improvements. Conclusion: This study suggests the viability of treating severe obesity by hospitalization with low-calorie diets and immersive lifestyle changes. …”
-
2011
-
2012
Characterization of systolic pulmonary arterial pressure (sPAP) of WT BMP9 in rats.
Published 2025Subjects: -
2013
Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i>
Published 2025Subjects: -
2014
-
2015
Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode.
Published 2025Subjects: -
2016
-
2017
Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode.
Published 2025Subjects: -
2018
-
2019
Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i>
Published 2025Subjects: -
2020